Compounds extracted from avocados might present an effective treatment option for a particular type of cancer. Acute Myeloid Leukemia (AML) is a highly destructive ailment, leading to a 90 percent fatality rate within five years for individuals aged 65 and above. This novel drug derived from avocados holds the potential to substantially enhance both the life expectancy and overall quality of life for AML patients in the future.
